Sign In
Buy PAYS
$6.81
-0.590 (-7.97%)
At Close: Jun 03, 2026
What Makes Paysign (PAYS) a New Buy Stock
01:00pm, Tuesday, 25'th Nov 2025
Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference
04:30pm, Thursday, 13'th Nov 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference.
Paysign, Inc. (PAYS) Q3 2025 Earnings Call Transcript
07:21pm, Wednesday, 12'th Nov 2025
Paysign, Inc. ( PAYS ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Mark Newcomer - Co-Founder, President & CEO Jeffery Baker - CFO & Treasurer Matthew Turner - President o
Paysign, Inc. Reports Third Quarter 2025 Financial Results
04:05pm, Wednesday, 12'th Nov 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Third Quarter 2025 Financial Results.
Paysign (PAYS) to Release Earnings on Wednesday
01:18am, Wednesday, 05'th Nov 2025
Paysign (NASDAQ: PAYS - Get Free Report) is anticipated to post its Q3 2025 results after the market closes on Wednesday, November 12th. Analysts expect Paysign to post earnings of $0.0350 per share a
Paysign to Host Third Quarter 2025 Earnings Call
04:15pm, Tuesday, 14'th Oct 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2025 Earnings Call.
Paysign: A Small-Cap Stock With Big Potential?
07:00pm, Thursday, 09'th Oct 2025
Explore the exciting world of Paysign (PAYS -1.42%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends
Paysign: Gaining Traction In The Patient Affordability Space Into 2026 (Hold)
07:04am, Wednesday, 01'st Oct 2025
Paysign posted strong Q2 2025 results, with 33% YoY revenue growth and robust Pharma segment momentum, driven by US tariffs and new client wins. PAYS is rated a hold, as the stock trades at fair value
Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions
08:05am, Monday, 22'nd Sep 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions.
Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
07:20pm, Monday, 15'th Sep 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions.
Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business
08:05am, Monday, 15'th Sep 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business.
Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference
04:30pm, Wednesday, 03'rd Sep 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference.
Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board
08:30am, Thursday, 14'th Aug 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board.
Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference
10:00am, Friday, 08'th Aug 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference.
Paysign, Inc. (PAYS) Q2 2025 Earnings Call Transcript
10:44pm, Tuesday, 05'th Aug 2025
Paysign, Inc. (NASDAQ:PAYS ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Jeffery B. Baker - CFO & Treasurer Mark R.
